Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin ...
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...
Getting your Trinity Audio player ready... From Odyssey for Democracy The president and founder of local nonprofit Odyssey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback